Pharmaceutical Medical Malpracitce Archives - Page 2 of 18

Judgment Ordered To Be Entered Against Johnson & Johnson And Others In Amount Of $1,059,840,000 For Mesothelioma Talc Verdict

December 29, 2025

ORDER FOR CLERK TO ENTER JUDGMENT On November 4, 2025 through December 22, 2025, this action was tried before a jury. All parties appeared with counsel. On December 22, 2025, the jury returned a verdict in favor of the Plaintiff, against Defendants Johnson & Johnson, Pecos River Talc LLC, Johnso[...]

$1.5 Billion Baltimore Mesothelioma Talc Verdict Against Johnson & Johnson

December 24, 2025

On December 22, 2025, a Baltimore City jury awarded over $1.5 billion to a woman who claimed that Johnson & Johnson’s baby powder talc contained asbestos that caused her peritoneal mesothelioma, which is a rare form of cancer that is linked to asbestos exposure and for which there is no cu[...]

Gilead Sciences Agrees To $202M Settlement For Using Speaker Programs To Pay Kickbacks To Doctors To Induce Them To Prescribe Gilead’s Drugs

June 25, 2025

On April 29, 2025, the United States Attorney for the Southern District of New York announced that the United States has settled a civil fraud lawsuit against Gilead Sciences, Inc. (“Gilead”), a large pharmaceutical manufacturer, that, among other things, develops, manufactures, and sells d[...]

California Medical Malpractice Lawsuit Alleges Side Effects Of Oxbryta Resulted In Death

June 8, 2025

A recently filed California medical malpractice lawsuit alleges that on March 28, 2024, Nbubuisi Madu tragically lost his life, after succumbing to the injuries suffered due to all Defendants’ negligence, which included sickle cell crisis, vaso occlusive crisis, veno-occlusive disease, acute c[...]

$335M Opioid Settlement Reached With Mylan Inc.

May 26, 2025

New York Attorney General Letitia James announced on April 7, 2025 that her office secured a multistate settlement in principle with pharmaceutical company Mylan Inc. (Mylan) that will deliver up to $335 million nationwide to help combat the opioid crisis. Mylan, which is now a part of Viatris, has [...]

Pharmaceutical Company Ordered To Pay Over $1.6B In False Claims Act HIV Drug Marketing Case

May 20, 2025

Relators filed a civil action behalf of the United States, twenty-six states, and the District of Columbia, alleging fifty-six counts under the federal False Claims Act (“FCA”), the federal Anti-Kickback Statute, and the false claims act of various states (“state FCAs”). The claims arose fro[...]

Federal Appellate Court Distinguishes Certain Drug Rebates From Unlawful Kickbacks

April 7, 2025

Regeneron Pharmaceuticals, Inc. manufactures Eylea. Eylea is one of just a few drugs approved by the Food and Drug Administration (FDA) for treating an ophthalmological condition called neovascular age-related macular degeneration, also known as wet AMD. Eylea is a “buy and bill” drug un[...]

Did Sudden $500 Spike In Asthma Inhaler Cost Lead To 22-Year-Old’s Death?

March 25, 2025

The parents of a 22-year-old asthmatic who died on January 20, 2024 after suffering an asthma attack for which he did not have his inhaler because he could not afford the increase in the out-of-pocket cost from $66 to $539 filed a lawsuit against the giant pharmacy benefits manager OptumRX and pharm[...]

FDA Investigating Listeria Outbreak In Nursing Homes Linked To Lyons ReadyCare And Sysco Imperial Frozen Supplemental Shakes

February 23, 2025

The FDA and CDC, in collaboration with state and local partners, are investigating illnesses in a multistate outbreak of Listeria monocytogenes infections linked to Lyons ReadyCare and Sysco Imperial Frozen Supplemental Shakes. On November 25, 2024, FDA was notified about an outbreak of&nb[...]

Teva Pharmaceuticals Will Pay $450M In False Claims Act Settlement To Resolve Kickback Allegations Relating To Copayments And Price Fixing

December 17, 2024

The United States Department of Justice announced on October 10, 2024 that Teva Pharmaceuticals USA Inc. (Teva USA) and Teva Neuroscience Inc. have agreed to pay $450 million to resolve two matters that allege Teva violated the Anti-Kickback Statute (AKS) and the False Claims Act (FCA). Teva, headqu[...]

Federal Appellate Court Rejects Preemption Of State Law Claims In Fosamax Litigation

November 27, 2024

The United States Court of Appeals for the Third Circuit stated in its precedential Opinion filed on September 20, 2024, “Drug manufacturers have the primary responsibility to ensure that the labels on their products comply with federal and state law. In this case, hundreds of Plaintiffs accus[...]

Walgreens Agrees To Pay $106.8M To Settle Allegations It Billed For Prescriptions Never Picked Up

November 8, 2024

The United States Department of Justice announced on September 13, 2024 that Walgreens Boots Alliance Inc. and Walgreen Co. (together, Walgreens) have agreed to pay $106.8 million to resolve alleged violations of the False Claims Act and state statutes for billing government health care programs for[...]

« 1 2 3 4 5 6 7 … 18 »

Category: Pharmaceutical Medical Malpracitce